Augmentation of mouse natural killer cell activity by muramyl dipeptide and its analogs. 1981

S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D005260 Female Females
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D000119 Acetylmuramyl-Alanyl-Isoglutamine Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity. Mur-NAc-L-Ala-D-isoGln,Muramyl Dipeptide,Acetylmuramyl Alanyl Isoglutamine,N-Acetyl-Muramyl-L-Alanyl-D-Glutamic-alpha-Amide,N-Acetylmuramyl-L-Alanyl-D-Isoglutamine,Alanyl Isoglutamine, Acetylmuramyl,Dipeptide, Muramyl,Isoglutamine, Acetylmuramyl Alanyl,Mur NAc L Ala D isoGln,N Acetyl Muramyl L Alanyl D Glutamic alpha Amide,N Acetylmuramyl L Alanyl D Isoglutamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001202 Ascitic Fluid The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. Peritoneal Effusion,Peritoneal Fluid,Ascitic Fluids,Effusion, Peritoneal,Fluid, Ascitic,Fluid, Peritoneal,Peritoneal Effusions,Peritoneal Fluids
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
January 1984, Microbiology and immunology,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
January 1979, Journal of immunology (Baltimore, Md. : 1950),
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
June 1985, Journal of immunology (Baltimore, Md. : 1950),
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
December 1980, Journal of the National Cancer Institute,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
April 1983, Infection and immunity,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
December 1979, Cellular immunology,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
February 1993, FEBS letters,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
December 1978, Pathologie-biologie,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
January 1987, Cancer immunology, immunotherapy : CII,
S D Sharma, and V Tsai, and J L Krahenbuhl, and J S Remington
June 1982, Immunopharmacology,
Copied contents to your clipboard!